Ajanta Pharma · NSE: AJANTPHARM · BSE: 532331

Q3 FY19 results · Oct–Dec 2018

Ajanta Pharma reported revenue from operations of ₹485.11 crore and net profit of ₹66.90 crore for Q3 FY19 (Oct–Dec 2018), on a consolidated basis.

Consolidated · ₹ crore
Item	Q3 FY19	Q3 FY18	YoY	Q2 FY19	QoQ
Revenue from operations	485.11	—	—	544.11	−10.8%
Other income	4.41	—	—	15.24	−71.1%
Total income	489.52	—	—	559.35	−12.5%
Profit before tax	92.96	—	—	163.84	−43.3%
Net profit for the period	66.90	—	—	125.39	−46.6%
EPS, basic (₹)	7.60	—	—	14.25	−46.7%
Net margin (%)	13.8	—		23.0

Standalone · ₹ crore
Item	Q3 FY19	Q3 FY18	YoY	Q2 FY19	QoQ
Revenue from operations	451.85	—	—	465.29	−2.9%
Other income	12.97	—	—	16.93	−23.4%
Total income	464.82	—	—	482.22	−3.6%
Profit before tax	125.70	—	—	141.98	−11.5%
Net profit for the period	95.47	—	—	104.10	−8.3%
EPS, basic (₹)	10.85	—	—	11.83	−8.3%
Net margin (%)	21.1	—		22.4

Consolidated

Standalone